Premium
Lixte Biotechnology Holdings Inc (LIXT)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Lixte Biotech Holdings Inc is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. The company focuses on developing new treatments for human cancers for which therapies ar... Lixte Biotech Holdings Inc is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. The company focuses on developing new treatments for human cancers for which therapies are urgently needed. It mainly designs drugs for which there are existing data suggesting any effect on altered pathways of the cancer cell and may be given safely to humans. The development program of the company includes drugs for the treatment of cancer, consisting of protein phosphatase inhibitors and histone deacetylase inhibitors. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.1407 | -10.0449775112 | 1.4007 | 1.46 | 1.25 | 47952 | 1.36007553 | CS |
| 4 | -1.14 | -47.5 | 2.4 | 3 | 1.25 | 158725 | 1.95856119 | CS |
| 12 | -0.96 | -43.2432432432 | 2.22 | 3 | 1.25 | 69702 | 2.01543463 | CS |
| 26 | -0.64 | -33.6842105263 | 1.9 | 3 | 1.25 | 348496 | 2.04985515 | CS |
| 52 | -0.87 | -40.8450704225 | 2.13 | 4.4 | 1.25 | 322509 | 2.67483332 | CS |
| 156 | -11.84 | -90.3816793893 | 13.1 | 49.5 | 1.25 | 562941 | 13.68153337 | CS |
| 260 | -37.24 | -96.7272727273 | 38.5 | 71.9 | 1.25 | 632657 | 20.37541019 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
